Spotlight on MASH (Formerly NASH): Exploring the Pathophysiology and Metabolic Impairments of a Progressive Liver Disease
Nov
13
2023
Product Theater 2, Exhibit Hall B
-
Hynes Convention Center
10:15
- 11:00 AM EST
Description
Supported by: Novo Nordisk
Join us as we review the pathophysiology of metabolic dysfunction-associated steatohepatitis (MASH, formerly known as NASH, non-alcoholic steatohepatitis), including the impact of underlying metabolic comorbidities. We will also explore the importance of early diagnosis and intervention for high-risk patients, review current management strategies and highlight the need for future therapies.
Presenter:
Mazen Noureddin, MD, MHSc